您的位置: 首页 > 农业专利 > 详情页

Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders
专利权人:
Santen SAS
发明人:
申请号:
EP12193075.4
公开号:
EP2564853B1
申请日:
2008.03.12
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention relates to a kind of surfaces for allowing to deliver corticosteroid human eye that a kind of new therapy approach is used to treat eye disease or situation, but will not cause any common adverse effect and local application corticosteroid. More specifically, the present invention provides including administration corticosteroid prodrug, such as dexamethasone palmitate for treating, to the surface of eyes. It additionally provides pharmaceutical composition and kit carries out this treatment method.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充